Aviex Technologies LLC was founded
to develop a novel vaccine platform delivery technology for infectious diseases.

The Company

Aviex is a leading-edge biotechnology company that is developing potent vaccines that are administered orally and/or by multi-modality utilizing a novel patented vaccine platform delivery technology.

The Aviex Platform is designed to deliver preventative and therapeutic vaccines for a wide range of human and animal infectious diseases caused by bacterial and parasitic pathogens. The company mission is to develop an ongoing pipeline of vaccine products utilizing the YS1646-based Aviex patented platform delivery technology.